BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 15094766)

  • 1. eIF4E--from translation to transformation.
    Mamane Y; Petroulakis E; Rong L; Yoshida K; Ler LW; Sonenberg N
    Oncogene; 2004 Apr; 23(18):3172-9. PubMed ID: 15094766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of translation in neoplastic transformation from a pathologist's point of view.
    Rosenwald IB
    Oncogene; 2004 Apr; 23(18):3230-47. PubMed ID: 15094773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of c-myc in regulation of translation initiation.
    Schmidt EV
    Oncogene; 2004 Apr; 23(18):3217-21. PubMed ID: 15094771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
    Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
    Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis.
    Zimmer SG; DeBenedetti A; Graff JR
    Anticancer Res; 2000; 20(3A):1343-51. PubMed ID: 10928042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
    Graff JR; Konicek BW; Carter JH; Marcusson EG
    Cancer Res; 2008 Feb; 68(3):631-4. PubMed ID: 18245460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.
    Topisirovic I; Ruiz-Gutierrez M; Borden KL
    Cancer Res; 2004 Dec; 64(23):8639-42. PubMed ID: 15574771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of eIF4 in cell proliferation.
    Flynn A; Proud CG
    Cancer Surv; 1996; 27():293-310. PubMed ID: 8909806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eIF-4E expression and its role in malignancies and metastases.
    De Benedetti A; Graff JR
    Oncogene; 2004 Apr; 23(18):3189-99. PubMed ID: 15094768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.
    Pervin S; Singh R; Hernandez E; Wu G; Chaudhuri G
    Cancer Res; 2007 Jan; 67(1):289-99. PubMed ID: 17210710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1.
    Tan A; Bitterman P; Sonenberg N; Peterson M; Polunovsky V
    Oncogene; 2000 Mar; 19(11):1437-47. PubMed ID: 10723135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray.
    Yang SX; Hewitt SM; Steinberg SM; Liewehr DJ; Swain SM
    Oncol Rep; 2007 Feb; 17(2):281-7. PubMed ID: 17203162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targets and mechanisms for the regulation of translation in malignant transformation.
    Clemens MJ
    Oncogene; 2004 Apr; 23(18):3180-8. PubMed ID: 15094767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-dependent translational control of senescence and transformation via 4E-BPs.
    Petroulakis E; Parsyan A; Dowling RJ; LeBacquer O; Martineau Y; Bidinosti M; Larsson O; Alain T; Rong L; Mamane Y; Paquet M; Furic L; Topisirovic I; Shahbazian D; Livingstone M; Costa-Mattioli M; Teodoro JG; Sonenberg N
    Cancer Cell; 2009 Nov; 16(5):439-46. PubMed ID: 19878875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
    Kröger A; Stirnweiss A; Pulverer JE; Klages K; Grashoff M; Reimann J; Hauser H
    Cancer Res; 2007 Apr; 67(7):2972-81. PubMed ID: 17409403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
    Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
    RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational upregulation of yes accompanies eIF4E-mediated oncogenic transformation.
    Defatta RJ; De Benedetti A
    Int J Oncol; 2003 Dec; 23(6):1709-13. PubMed ID: 14612945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis.
    Ruggero D; Montanaro L; Ma L; Xu W; Londei P; Cordon-Cardo C; Pandolfi PP
    Nat Med; 2004 May; 10(5):484-6. PubMed ID: 15098029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathways leading to increased eIF4E phosphorylation caused by oxidative stress.
    Duncan RF; Peterson H; Sevanian A
    Free Radic Biol Med; 2005 Mar; 38(5):631-43. PubMed ID: 15683719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.